Company profile

Ciloa SAS

Harnessing natural messengers for innovative therapeutics

Industry
Biotechnology Research
Employees
13
Headquarters
Montpellier
Founded
2011
Office locations
1

Ciloa SAS company summary

Ciloa SAS is a company in the Biotechnology Research industry, headquartered in Montpellier, founded in 2011. On LinkedIn the company has around 13 employees. Its listed specialties include Screening ligand binding to membrane receptors, Development of native transmembrane proteins, Development of therapeutic antibodies, Development of vaccines, Development of therapeutic vectors.

What technology does Ciloa SAS use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About Ciloa SAS

Ciloa is a pioneer in the bioengineering of extracellular vesicles to develop new generations of therapeutics and preventive solutions to improve patients' lives. Ciloa bioengineers sEV proteins, to turn them into natural messengers with huge medical potential. Our bioengineered sEVs can be used as therapeutic solutions in a number of medical fields, including oncology, metabolic diseases, rare diseases and age-related illnesses. Mastering sEV engineering, we have produced sEVs containing a stable, highly multimerised and functional adiponectin (APN), a hormone well known as our “Guardian Angel” for its insulin-sensitizing, anti-inflammatory and anti-oxidative stress properties. Ciloa’s platform, EVENGI, has generated over a hundred sEVs containing various proteins of medical interest. Thanks to our 20 years’ experience in the field of EVs, we have developed a robust sEV production, purification and qualification process that can be scaled up under industrial conditions. This EV production platform has enabled us to produce dozens of bioengineered sEVs that are stable in the refrigerator for years as ready-to-use, affordable medicines.

Specialties

Screening ligand binding to membrane receptorsDevelopment of native transmembrane proteinsDevelopment of therapeutic antibodiesDevelopment of vaccinesDevelopment of therapeutic vectorsPioneer of exosome based therapies and vaccinesMetabolic diseases therapiesAdiponectin on sEVsSmall Extracellular vesicles therapies and vaccines

Where is Ciloa SAS located?

Ciloa SAS lists 1 location.

Montpellier, 34080, FRHQ
356 rue Maurice Bejart

Compare companies similar to Ciloa SAS

More companies in Biotechnology Research.

CompanyIndustryEmployeesFoundedHeadquarters
Ciloa SAS
ciloa.bio
Biotechnology Research132011Montpellier
Thermo Fisher Scientific
thermofisher.com
Biotechnology Research100,779-Waltham, MA
Amgen
amgen.com
Biotechnology Research41,0281980Thousand Oaks, CA
Biogen
biogen.com
Biotechnology Research7,742-Cambridge, MA
Biocon
biocon.com
Biotechnology Research11,902-Bangalore, Karnataka
Biotechnology Research28,679-Bethesda, MD
Genentech
gene.com
Biotechnology Research18,2961976South San Francisco, California
Eurofins
eurofins.com
Biotechnology Research24,928-Luxembourg, Luxembourg
Gilead Sciences
gilead.com
Biotechnology Research14,743-Foster City, CA
Syneos Health
syneoshealth.com
Biotechnology Research23,772-Morrisville, NC
Moderna
modernatx.com
Biotechnology Research6,2382010Cambridge, Massachusetts

Frequently asked questions about Ciloa SAS

What does Ciloa SAS do?

Ciloa is a pioneer in the bioengineering of extracellular vesicles to develop new generations of therapeutics and preventive solutions to improve patients' lives. Ciloa bioengineers sEV proteins, to turn them into natural messengers with huge medical potential. Our bioengineered sEVs can be used as therapeutic solutions in a number of medical fields, including oncology, metabolic diseases, rare diseases and age-related illnesses. Mastering sEV engineering, we have produced sEVs containing a stable, highly multimerised and functional adiponectin (APN), a hormone well known as our “Guardian Angel” for its insulin-sensitizing, anti-inflammatory and anti-oxidative stress properties. Ciloa’s platform, EVENGI, has generated over a hundred sEVs containing various proteins of medical interest. Thanks to our 20 years’ experience in the field of EVs, we have developed a robust sEV production, purification and qualification process that can be scaled up under industrial conditions. This EV production platform has enabled us to produce dozens of bioengineered sEVs that are stable in the refrigerator for years as ready-to-use, affordable medicines.

How many employees does Ciloa SAS have?

Ciloa SAS has around 13 employees on LinkedIn.

Where is Ciloa SAS headquartered?

Ciloa SAS is headquartered in Montpellier.

When was Ciloa SAS founded?

Ciloa SAS was founded in 2011.

Build a lead list from companies like Ciloa SAS

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.